|
Date of decision
|
10 July 2006
|
|
|
Case number
|
T 0833/03
- 3.3.02
|
|
|
Application number
|
94902475.6
|
|
|
|
|
|
|
Title of the application
|
Controlled release growth hormone containing microspheres
|
|
|
Applicant name
|
Alkermes Controlled Therapeutics, Inc.
|
|
|
Opponent name
|
Novo Nordisk A/S
Bioglan Pharma PLC
Takeda Chemical Industries, Ltd.
|
|
|
|
|
Keywords
Main request - sufficiency of disclosure - yes: specific
mechanism for a specific embodiment of the claims disclosed in
the description
|
|
|
|
|